EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis

Xiaxin Zhu, Chi Zhang, Shuyan Feng, Ruonan He, Shuo Zhang

Clinical and Experimental Medicine · 22.02.2024 · 24 (1)

DOI: 10.1007/s10238-024-01304-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 22.02.2024. Verfasst von Xiaxin Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. Hauptthemen laut MEDLINE: Hashimoto Disease, Gastrointestinal Microbiome, Autoimmune Diseases. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Fund Project of Zhejiang Chinese Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal microbiota plays an indispensable role in the host's innate immune system, which may be related to the occurrence of many autoimmune diseases. Hashimoto thyroiditis (HT) is one of the most common autoimmune diseases, and there is plenty of evidence indicating that HT may be related to genetics and environmental triggers, but the specific mechanism has not been proven clearly. Significantly, the composition and abundance of intestinal microbiota in patients with HT have an obvious difference. This phenomenon led us to think about whether intestinal microbiota can affect the progress of HT through some mechanisms. By summarizing the potential mechanism of intestinal microflora in regulating Hashimoto thyroiditis, this article explores the possibility of improving HT by regulating intestinal microbiota and summarizes relevant biomarkers as therapeutic targets, which provide new ideas for the clinical diagnosis and treatment of Hashimoto thyroiditis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hashimoto DiseaseGastrointestinal MicrobiomeAutoimmune DiseasesHumans

Stichwörter der Autor:innen

Autoimmune diseaseBiomarkerGut-thyroid axisHashimoto thyroiditisIntestinal microbiota

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.
  • Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, 310018, People's Republic of China.
  • The Second Affiliated Hospital of Zhejiang Chinese Medical University (The Xin Hua Hospital of Zhejiang Province), No. 318 Chaowang Road, Hangzhou, 310005, Zhejiang, People's Republic of China. zhangshuotcm@126.com.

Förderung

  • National Natural Science Foundation of China
  • Research Fund Project of Zhejiang Chinese Medical University

Zitieren

APA

Zhu, X., Zhang, C., Feng, S., He, R., & Zhang, S. (2024). Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01304-4

Vancouver

Zhu X, Zhang C, Feng S, He R, Zhang S. Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01304-4

BibTeX
@article{Zhu2024,
  author = {Zhu, Xiaxin and Zhang, Chi and Feng, Shuyan and He, Ruonan and Zhang, Shuo},
  title = {Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1007/s10238-024-01304-4}
}
Kostenlos starten →